Moreover, the combined signature of high CHRNA5 transcript levels with OSCC type predicted a worse prognosis in terms of recurrence-free survival probability in HNSCC patients receiving radiation therapy (Figure 2D). The gene discussed is CHRNA5; the disease is head and neck squamous cell carcinoma.